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Abstract Research on the contribution of positive personality traits to the progression of 
coronary heart disease (CHD) is notably absent. Resilience is the capacity to develop oneself 
successfully despite adverse circumstances. In a study of patients with acute coronary syndrome 
(ACS), the authors investigated the effect of resilience on indicators of CV severity and the 
physiological mechanisms underlying this effect. Patients (n=134) completed a scale measuring 
resilience. The authors measured troponin-I and myoglobin as indicators of ACS severity, and 
white blood cell (WBC) count and neutrophils as inflammatory markers. Results showed that 
self-efficacy-a component of resilience-was negatively related to both myoglobin and troponin 
after the acute coronary event. The relationship between resilience and these prognostic 
markers was mediated by the WBC count. Importantly, this result held significant after 
controlling for the effect of classic CV risk factors and demographics. The authors conclude that 
resilience decreases the extent of the myocardial infarction by affecting the inflammatory 
response, showing a protective effect.
© 2013 Asociación Española de Psicología Conductual. Published by Elsevier España, S.L.  
All rights reserved.
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Resumen En la actualidad la investigación sobre la influencia de los rasgos de personali-
dad positivos sobre la enfermedad coronaria (EC) es escasa. La resiliencia se define como 
la capacidad para autodesarrollarse con éxito a pesar de las circunstancias adversas. En un 
estudio, los autores han investigado el efecto de la resiliencia en varios indicadores de 
severidad en pacientes con síndrome coronario agudo (SCA; n=134) y los mecanismos que 
subyacen a este efecto. Los pacientes completaron una escala que medían sus niveles de 
resiliencia. Los autores midieron los niveles de troponina-I y mioglobina como indicadores 
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Cardiovascular disease (CVD) is a major public health 
burden in the industrialized countries, including the United 
States and Europe (World Health Organization [WHO], 
2011). Most recent estimates from the American Heart 
Association suggest that one third of American adults (i.e., 
nearly 80 million people) have some form of CVD (Roger et 
al., 2012). The most common forms are: coronary heart 
disease (CHD), chest pain, heart failure, and stroke (Roger, 
Go, Lloyd-Jones, Adams, Berry, Brown, 2011). Data from 
prospective-cohort and case-control studies showed that 
modifiable risk factors (e.g., smoking, high lipid levels, 
obesity, physical inactivity, low daily fruit and vegetable 
consumption, and alcohol overconsumption) are important 
predictors of risk of CVD (Yusuf et al., 2004). 
There is also a growing body of literature showing that 
psychological factors play a crucial role in adverse 
cardiovascular outcomes (Pelle, Denollet, Zwisler, & 
Pedersen, 2009). To illustrate, methodologically sound 
epidemiological studies indicated that negative emotions, 
including stress, and sub-facets of negative affectivity 
(e.g., depression) contribute to the initiation and 
progression of CVD (Denollet, Freedland, Carney, de Jonge, 
& Roest, 2013). People who have had heart attacks suggest 
stress as the cause of their disorder (Cameron, Petrie, Ellis, 
Buick, & Weinman, 2005). Evidence for the role of stress as 
a precipitating factor for heart attack in people with CVD is 
also clear: Stress increases risk (Arnold, Smolderen, 
Buchanan, Li, & Spertus, 2012). A large cross-cultural study, 
the INTERHEART study (Yusuf et al., 2004), compared more 
than 15,000 people who had experienced a myocardial 
infarction (MI) with almost as many who had not, attempting 
to identify significant risk factors that held across cultures. 
This study identified a set of stressors that showed a 
significant relationship to MI, including workplace and 
home stress and major life events. These stress factors 
were significantly related to MI and made a substantial 
contribution to the risk. 
Depression is also a major contributor to CVD. Depression 
is common among individuals with heart disease especially 
after acute MI, with more than 1 in 5 patients meeting 
diagnostic criteria (Thombs et al., 2008). Depression is 
3 times more common in patients after acute MI than in the 
general community (Thombs et al., 2006). Depression 
during hospitalization is associated with more than 3-fold 
increased risk of CHD within 18 months of the hospitalization 
(Dragu et al., 2008). Moreover, in a study of 5-year CHD 
survival among cardiac patients, Lesperance, Frasure-
Smith, Talajic, and Bourassa (2002) showed that increases 
in the level of depression were associated with dose-
response increases in CHD risk.
Interestingly, research investigating the effect of positive 
emotions, cognitions, and personality traits to the initiation 
and progression of CHD has been notably absent. In 
addition, the few studies on this issue did not explore 
possible physiological mechanisms underlying their effect 
(Tugade, Fredrickson, & Barrett, 2004). To illustrate, the 
tendency to hold optimistic beliefs about the future has 
been found to be associated with better cardiovascular 
health in some prospective studies (Tindle et al., 2009). 
The effects of optimistic beliefs include lower incidence of 
CHD and risk of cardiovascular death, and better prognosis 
following heart surgery (Giltay, Kamphuis, Kalmijn, Zitman, 
& Kromhout, 2006; Kubzansky, Sparrow, Vokonas, & 
Kawachi, 2001). 
Another concept related to CVD that is gaining momentum 
is resilience-or the capacity to overcome adverse events 
and to be able to develop oneself successfully despite very 
adverse circumstances (e.g., death of family members, 
wars, serious traumas; Ali, Dwyer, Vanner, & Lopez, 2010; 
Bonanno, 2004; Seery, 2011; Zautra, Hall, & Murray, 2010). 
Resilience is related to the way individuals cope, overcome, 
and become positively strengthened by changes and 
challenges and has been largely studied in younger 
and older adults (Fry & Keyes, 2010). Resilient individuals 
use positive emotions to rebound from stressful experiences 
quickly and effectively (Giltay et al., 2006), and find 
positive meaning in negative circumstances. 
Resilient individuals have also been found to build 
supportive social networks that facilitate coping, and to 
show a faster cardiovascular recovery after negative events 
(Tugade et al., 2004). For instance, Tugade and Fredrickson 
(2004) measured cardiovascular responding to a laboratory 
stressor in a sample of undergraduates. Six indices of 
cardiovascular responding were collected, including heart 
rate, finger pulse amplitude, pulse transmission times to the 
finger and the ear, and diastolic and systolic blood pressure. 
The authors calculated an aggregate index of duration of 
cardiovascular reactivity (time to return to baseline levels) 
for each participant by computing the mean duration score 
across these six indices, and showed that participants with 
higher resilience evidenced faster cardiovascular recovery 
from negative emotional arousal. Similarly, Chan, Lai, and 
Wong (2006) showed that CHD patients with higher resilience 
achieve better health outcomes than low-resilient CHD 
patients in response to an 8-week rehabilitation program, as 
indicated by higher physical and mental measures, lower 
de la severidad del SCA, y el número total de glóbulos blancos (NGB) y neutrófilos como 
marcadores de inflamación. Los resultados han puesto de manifiesto que el nivel de auto-
eficacia —un componente de la resiliencia— se relaciona negativamente con los niveles de 
mioglobina y troponina después de un evento coronario agudo. La relación entre la resi-
liencia y estos marcadores está mediada por el NGB. Este resultado se mantiene tras con-
trolar el efecto de los factores cardiovasculares clásicos y demográficos. Los autores 
concluyen que la resiliencia reduce la extensión del infarto de miocardio influyendo en la 
respuesta inflamatoria, mostrando un efecto protector.
© 2013 Asociación Española de Psicología Conductual. Publicado por Elsevier España, S.L.  
Todos los derechos reservados.
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cholesterol levels, and better performance on a walk test. 
Moreover, resilience was a significant predictor of 
posttraumatic growth related to the onset of heart disease, 
indicating that CHD patients with higher resilience showed 
more posttraumatic growth than patients with lower 
resilience. However, there is a dearth of research 
investigating the effect of resilience on indicators of CVD 
severity and the physiological mechanisms underlying this 
effect (Feder, Nestler, Westphal, & Charney, 2010). 
A number of pathophysiological mechanisms have been 
proposed to explain the relationship between psychological 
factors and cardiovascular outcomes, including 
hypothalamic-pituitary-adrenal axis dysregulation, platelet 
activation, and inflammation (Cohen et al., 2012). 
Circulating inflammatory markers are important predictors 
of cardiac risk, as they are often associated with increased 
incidence of adverse cardiac events (Sabatine et al., 2002) 
as well as increased mortality after controlling for 
conventional risk factors (Ikonomidis, Stamatelopoulos, 
Lekakis, Vamvakou, & Kremastinos, 2008). For instance, 
increases in interleukin (IL)-6, tumor necrosis factor alpha, 
and C-reactive protein play an important role in the 
pathogenesis and progression of CVD and are associated 
with various psychosocial factors including early life 
adversity, stress, hostility, and social isolation (Steptoe, 
Hamer, & Chida, 2007). The total white blood cell (WBC) 
count and the percentage of neutrophils are also predictors 
of cardiovascular outcomes (Cabrerizo-García, Zalba, 
Pérez, & Ruiz, 2010). In fact, a recent systematic review 
showed that the percentage of neutrophils measured 
on-admission are related to mortality rate and/or to major 
adverse clinical events in patients with acute coronary 
syndrome (ACS; Guasti et al., 2011).
In the current research, we investigated whether 
resilience influences cardiovascular prognosis in patients 
with ACS. In particular, we investigated whether 
resilience affects levels of troponin-I and myoglobin-two 
cardiac enzymes that are released to the vascular system 
after a myocardial infarction. These enzymes serve as 
sensitive and specific indicators of damage to the 
myocardium and tend to be reliable indicators of ACS 
severity in clinical practice (Thygesen et al., 2012). Peak 
levels of these enzymes after an acute coronary event 
correlate with the extension of the MI and provide 
important prognostic information (Heidenreich et al., 
2001). We also investigated the physiological mechanisms 
underlying the effect of resilience on ACS severity. 
Following Feder et al. (2010), we examined whether this 
effect is mediated by inflammation (i.e., total WBC 
count and percentage of neutrophils). In our analyses we 
controlled for the effect of risk factors including age, 
sex, hypertension, diabetes, dyslipidemia, smoking, and 
body mass index (BMI).
Method
Sample
Our participants were 134 consecutive patients (average 
age of 61.8 years, SD=9.80, range 31-82; 82% males) who 
were admitted to the hospital “Virgen de las Nieves” of the 
University of Granada with ACS. Patients’ sociodemographic 
features are displayed in Tables 1 and 2. Half of the patients 
had dyslipidemia and ST elevation*; one third smoked 
and had diabetes; and almost 60% had hypertension. 
Patients with or without ST-segment elevation were eligible 
to participate in the study. The inclusion criteria for 
participation were having elevated cardiac markers (i.e., 
Troponin-I) and having ischemia. The exclusion criterion 
were having an inflammatory disease and/or having 
neurological problems. Seventy-nine percent of the 
Table 1 Percentage of patients with classical risk factors 
and ST elevation.
Variable No Yes Statistical test
Smoking 84 50 c2=8.63, p<.01 
Hypertension 57 77 c2=2.985, p>.08
Diabetes 87 47 c2=11.94, p<.01
Dyslipidemia 64 70 c2=.27, p>.60
ST elevation 67 67 c2=.00, p=1.00
Table 2 Averages, 95% confidence intervals (CI), standard error of the mean (SEM), and median of resilience factors and 
biochemical markers.
Factor Average 95% CI LL 95% CI UL SEM Median
Age 61.80 60.12 63.47 0.85 63.00
BMI 28.77 28.01 29.53 0.38 28.03
Troponin I 31.49 25.10 37.89 3.23 13.94
Myoglobin 496.29 370.18 622.41 63.76 200.35
WBF 10.23 9.59 10.87 0.32 9.39
Neutrophils 69.86 67.80 71.92 1.04 70.70
RS self-efficacy 59.21 57.31 61.11 0.96 62.00
RS purpose 31.14 30.12 32.17 0.52 31.50
RS Cognitive Avoidance 39.15 38.01 40.29 0.58 40.50
* A ST-segment elevation myocardial infarction (STEMI) usually 
reflect an acute coronary occlusion and indicates a poor early-term 
clinical outcome, whereas a non-STEMI (NSTEMI) usually reflect a 
critically ill but not complete coronary artery obstruction and 
indicates a poor long-term clinical outcome (Park et al., 2013).
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approached patients were eligible and agreed to participate 
in the study. Patients were recruited prospectively between 
July 2011 and December 2011 at bedside 3 days after the 
ACS. Patients were recruited by a trained assistant, who 
described the purpose of the study and answered questions. 
We followed the guidelines of the European Society of 
Cardiology for diagnosis (see ESC Guidelines, 2007) to 
recruit participants. The Ethics Committee of the Hospital 
“Virgen de las Nieves” of the University of Granada 
approved the methodology of the study. All participants 
signed an informed consent form to participate in the 
study.
Instruments and procedure
Participants’ demographics, anthropometric, and laboratory 
data-including fasting lipid profile and serum glucose-were 
measured at baseline. We measured age, sex, height, and 
weight in all participants. All participants provided a 
medical history and underwent a clinical examination. 
Standardized questionnaires were used to determine 
participants’ medical history, medication use, and their 
cardiovascular risk. Participants were classified as 
hypertensive if they (a) had an average systolic blood 
pressure of >140 mm Hg and/or a diastolic blood pressure 
of >90 mm Hg at rest, (b) had previous history of 
hypertension, or (c) were taking antihypertensive drugs. 
Patients were classified as diabetics if they (a) had fasting 
blood glucose of >126 mg/dL, (b) had previous history of 
diabetes mellitus, or (c) were taking insulin/oral 
hypoglycemics. A fasting venous sample was collected in all 
patients, and total cholesterol, high-density lipoprotein 
(HDL), low-density lipoprotein (LDL), and triglyceride levels 
were determined by standard enzymatic methods. 
Resilience. Participants completed the Wagnild and 
Young (1993) Resilience Scale (RS), which is a 25 item 
Likert-type rating scale that measures degree of resilience. 
It includes a number of protective health factors such as 
self-esteem, flexibility, ability to deal with conflict, 
availability of external support, and familiar cohesion. The 
scale was translated into Spanish by skilled translators. 
The translated version showed very good psychometrics 
(Cronbach’s alpha = .90). Previous research identified two 
(Heilemann, Lee, & Kury, 2003; Wagnild & Young, 1993) or 
three components (Rodríguez et al., 2009) in exploratory 
factor analyses. We conducted an exploratory factor 
analysis with principal components extraction and Varimax 
rotation. With resul ts consistent with previous research, 
we identified the following three components in this 
analysis (KMO=0.76, Bartlett sphericity test p<.001): self-
efficacy, or the ability to cope with difficult and complex 
situations as well as the strength to do it (Cronbach’s 
alpha=.86; 11 items, examples of items are “I usually 
manage one way or another,” and “I am able to depend on 
myself more than anyone else”); purpose, or the ability to 
stay motivated over time and be operative (Cronbach’s 
alpha=.75; 6 items, examples of items are “When I make 
plans, I follow through with them,” and “I am determined”); 
and meaning of life and cognitive avoidance, or the ability 
to find positive aspects in life events, and to avoid dealing 
with situations when you cannot change them (Cronbach’s 
alpha=.73; 7 items, examples of items are “I feel proud 
that I have accomplished things in life,” and “I do not 
dwell on things that I can’t do anything about”). One item 
(“I seldom wonder what the point of it all is”) did no load 
in any of the three factors. 
After completing this scale, participants answered other 
unrelated questions. These results will be reported 
elsewhere. Participants completed the questionnaires at 
bedside while they stated at the Hospital “Virgen de las 
Nieves.” There were no time constraints, but the 
questionnaire took approximately 30 min to complete. 
Biochemical markers. We measured the following 
markers:
1.  Indicators of ACS severity. Venous samples were collected 
in all patients at admission, and 3, 6, and 12 h. after 
admission. We used standard enzymatic methods to 
measure peak levels of cardiac damage enzymes after 
the coronary event (i.e., troponin-I and myoglobin). 
2.  Inflammatory markers. Venous samples were collected in 
all patients at admission and leucocytes (i.e., total WBC 
count) and percentage of neutrophils were measured 
using standard methods.
Statistical analyses
Demographics and characteristics of the sample of 
participants were analyzed using descriptive statistics and 
c2 statistical tests (Table 1; see Montero & León, 2007; 
Ramos-Alvarez, Moreno-Fernández, Valdés-Conroy, & 
Catena, 2008). Biochemical markers and resilience were 
positively skewed (Table 2). Therefore, we computed non-
parametric Spearman rho correlations. 
Troponin-I, WBC count, neutrophils, and components of 
resilience were converted into binary variables using their 
corresponding medians as cut points. BMI was dichotomized 
by using the standard value of 25. We defined two clusters 
of variables: predictor variables (the three components of 
resilience, i.e., RS self-efficacy; RS purpose; and SRRS) and 
control variables (ST elevation; classical risk factors 
including age, sex, hypertension, diabetes, dyslipidemia, 
smoking, and BMI; and inflammatory markers including WBC 
count and neutrophils).
We conducted logistic regression analyses to test whether 
predictor and control variables predict severity of ACS 
severity (i.e., levels of troponin-I and myoglobine) (Model I). 
Significant predictor and control variables were then 
submitted to a hierarchical logistic multiple regression 
analysis to determine whether significant components of 
resilience improve the prediction of severity of ACS after 
including significant control variables in the equation 
(Model II). Odds ratios were computed to evaluate the 
effect size of the variables. Chi-square test and Nagelkerke 
R2 were computed to evaluate improvements in predictive 
power when components of resilience were added to Model II. 
The Hosmer-Lemeshow test was used as the goodness-of-fit 
test of regression models. 
To investigate whether the relationship between 
resilience and severity of ACS is mediated by inflammatory 
markers, we conducted mediational analyses following 
Preacher and Hayes (2008), with components of resilience 
as predictors, indicators of ACS severity as the criterion 
variables, and the significant inflammatory markers (i.e., 
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WBF and neutrophils) as mediators. Indirect effects were 
tested by using an accelerated and bias corrected 
bootstrap procedure (5000 samples), implemented in the 
Preacher and Hayes’ PROCESS macro. Variables were mean 
centered, and heterocedasticity consistent standard 
errors were used. In the analyses, we controlled for the 
effect of ECG ST deviation and classical risk factors by 
including these variables as covariates. Inflammatory 
markers were also included as moderators in the analyses 
to test whether they modulate (rather than mediate) the 
effect of components of resilience on severity of ACS. All 
the statistical decisions were conducted using a two-sided 
.05 significance level.
Results
Resilience, severity of acute coronary syndrome, 
and inflammatory markers
Table 3 shows the relationships between components 
of resilience, inflammatory markers, and indicators of 
ACS severity. RS self-efficacy is related to severity of ACS 
(troponin-I, r= −.21, p=.02, and myoglobine, r= −.17, p=.05) 
and WBC count (r= −.19, p=.03). In contrast, RS purpose 
and cognitive avoidance are not related to ACS severity or 
inflammatory markers. In addition, RS purpose is related to 
age (r=.23, p=.01) and hypertension (r=.21, p=.02). In 
addition, most of the classical risk factors were related to 
troponin I (age, r= −.22, p=.01, diabetes, r= −.23, p=.01, 
smoking habits, r=.19, p=.03), myoglobine (age, 
r= −.20, p=.02, sex, r= −.24, p=.01, diabetes, r= −.18, 
p=.04), and WBC count (age, r= −.25, p=.003, sex, r= −.23, 
p=.01). Finally, ST elevation was associated to troponin-I 
(r=.61, p<.001), myoglobine (r=.58, p<.001), WBC count 
(r=.27, p=.001), and neutrophils r=.25, p=.004). 
Logistic regression on troponin-I (Model I) indicated that 
ST elevation, inflammatory markers, and classical risk 
factors accounted for a significant amount of variability 
(block c²(8)=65.88, p<.001, Nagelkerke R2=.52, HL c²(8)=8.75, 
p=.36, 78% correct classifications). However, only ST 
elevation (reference category: STEMI, OR=7.90, p<.001) 
and WBC count (reference category: low level, OR=4.95, 
p=.003) were significant. The predictive power of Model II 
was also significant (block c²(8)=9.91, p=.002, Nagelkerke 
R2=.58, HL c²(8)=13.14, p=.11, 83% correct classifications). 
RS self-efficacy significantly improved predictive power 
(reference category: High self-efficacy, OR=5.04, p=.003), 
indicating that patients with low RS self-efficacy tended to 
have higher levels of troponin-I than those with high levels 
of RS self-efficacy. 
Logistic regression on myoglobine (Model I) indicated that 
ST elevation and classical risk factors accounted for a 
significant amount of variability (block c²(8)=57.37, p<.001, 
Nagelkerke R2=.46, HL c²(8)=3.35, p=.91). Only ST elevation 
(reference category: STEMI, OR=7.29, p<.001), sex (reference 
category: female, OR=4.33, p=.03), and WBC count 
(reference category: low counts, OR=4.08, p=.01) were 
significant. The predictive power of Model II was also 
significant (block c²(8)=7.01, p=.01, Nagelkerke R2=.51, HL 
c²(8)=12.69, p=0.12). RS self-efficacy significantly improved 
prediction power (reference category: High self-efficacy, 
OR=3.55, p=0.01), indicating that patients with low RS self-
efficacy tended to have higher levels of myoglobine than 
those with high RS self-efficacy.
Mechanism explaining the relationship between 
resilience and severity of acute coronary syndrome
When WBC count was included as a mediator in the 
regression analysis, the relationship between RS self-
efficacy and troponin-I remained significant (c’ path= 
−1.72, p=.017; see Figure 1). The relationship between RS 
self-efficacy and WBC count (a) and between WBC count 
and troponin-I (b) was also significant (a= −.36, p=.04, 
b=2.28, p<.001). Both the total (estimate= −2.53, p=.001) 
and indirect effects (Bootstrap estimated effect: −.80 95% 
CI [−1.81, −.12]) of RS self-efficacy on troponin-I were 
significant. In addition, our analysis showed that WBC count 
act as a mediator rather than as a moderator of the 
relationship between RS self-efficacy and troponin-I, 
F(1,122)=0.689, p>.41.
Finally, when WBC count was included as a mediator in 
the regression analysis, the relationship between RS self-
efficacy and myoglobine was not significant (c’ path= −.29, 
p=.52; see Figure 2). In contrast, the relationship between 
RS self-efficacy and leukocytes (a) and between leukocytes 
and troponin-I (b) were significant (a= −.35, p=.038, b=1.42, 
p<.001). The total (estimate= −.79, p=.04) and indirect 
effects of RS self-efficacy on myoglobine (Bootstrap 
estimated effect: −.50 95%CI [−1.07, −.08]) were significant. 
Again, our analysis showed that WBC count acts as a 
mediator rather than as a moderator of the relationship 
between RS self-efficacy and myoglobine, F(1,122)=.74, 
p=.39.
Discussion
In this study, we aimed at investigating the influence of 
resilience on biological parameters of inflammation and 
severity in the acute setting of an ACS. Results showed that 
Table 3 Correlations between psychological variables, inflammatory markers, and indicators of ACS severity. 
 My Lk N RS-Self Efficacy RS-Purpose RS-Cognitive Avoidance
Troponin I (T-I) .84*** .44*** .30*** −.21* −.06 −.07
Myoglobin (My)  .48*** .36*** .17+ .07 −.08
Leukocytes (Lk)   .57** −.19* −.06 −.08
Neutrophils (N)    −.01 .07 −.05
** p< .001; * p< .05; + p< .10.
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self-efficacy—a component of resilience—was negatively 
related to peak levels of both troponin and myoglobine 
after an acute coronary event. Both myoglobine and 
troponin are important cardiac enzymes that are released 
after necrosis of the myocardium in the context of an acute 
coronary event. They are considered as prognostic markers 
as they reflect the magnitude of necrosis. Our results 
further showed that the relationship between self-efficacy 
and these prognostic markers was partially mediated by 
WBC count (i.e., an inflammatory marker). Importantly, 
this result held significant after controlling for the effect 
of ST elevation, patients’ age, sex, body mass index, 
smoking habits, HTA, diabetes, and dyslipidemia. Thus, 
self-efficacy might influence the size of the myocardial 
infarction by affecting the inflammatory response, showing 
a protective effect.
Published research converges to suggest that there is a 
direct relationship between inflammation and coronary 
atherosclerosis both in acute and chronic settings (He, 
Tang, Ling, Chen, & Chen, 2010). Previous research (e.g., 
Cabrerizo-García et al., 2010; Dragu et al., 2008) also 
indicated that WBC count and percentage of neutrophils at 
admission are related to cardiovascular prognosis after an 
acute coronary event. In addition, Duivis et al., (2012) 
showed that depression predicts subsequent inflammation 
(e.g., leukocytes) in patients with stable CHD. In contrast, 
baseline levels of WBC count do not predict subsequent 
depressive symptoms, suggesting that depression is a risk-
factor for inflammation which, in turn, predicts CHD. With 
our study, we add to this body of literature showing that 
the protective effect of resilience on CHD is also mediated 
by inflammation. In alignment with previous research, we 
assume that resilience might reduce inflammation rather 
than the other way around. This conclusion is supported by 
the fact that resilience is a personality trait relatively 
stable across long time periods (Bonanno, 2004; Seery, 
2011; Wagnild, 2009). Therefore, it might not be influenced 
by transient levels of inflammation. 
Our results are also consistent with research by Ikeda et 
al. (2011), who indicated that optimism, another positive 
Figure 1 Path scheme of the effect of RS self-efficacy on troponin-I and the mediator effect of leukocytes. In the analyses, we 
controlled for the effect of ST elevation and classical risk factors. Only significant and almost significant factors were displayed. 
Note: Estimated coefficients are shown. 
* p < .05, ** p < .01, *** p = .09.
Figure 2 Path scheme of the effect of RS self-efficacy on myoglobine and the mediator effect of leukocytes. In the analyses, we 
controlled for the effect of ST elevation and classical risk factors. Only significant and almost significant factors were displayed. 
Note: Estimated coefficients are shown.
* p<.05, ** p<.01, *** p=.09.
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personality trait, also has a protective effect for CHD by 
reducing inflammation. In particular, the authors showed 
that higher overall optimism scores were associated to 
lower levels of interleuking-6—a cytokine with an important 
role in the inflammatory acute phase response. The study 
by Ikeda et al. (2011), however, was conducted in older 
men, free of CHD. Our research therefore is the first 
indicating that a positive personality trait tends to reduce 
inflammation in the context of an ACS and in turn influence 
the prognosis of CHD.
The potential mechanism by which psychological 
factors affect WBC count is not completely understood. 
Duivis et al., (2011) indicated that unhealthy behaviors 
explained the relation between depressive symptoms 
and the subsequent increase in the level of inflammatory 
cytokines in patients with stable CHD. However, these 
authors also showed that the relationship between 
depressive symptoms and levels of leukocytes were not 
related to levels of cytokines, BMI, waist-hip ratio, 
physical activity, or smoking. Therefore, the practice of 
health-damaging behaviors might not explain why self-
efficacy influences WBC count. Other plausible 
explanations of this effect is the influence of chronic 
stress (Widmaier, Raff, & Strang, 2011), the sleep 
disturbance and poor sleep quality (Duivis et al., 2012), 
or the induction of hypercortisolemia or reduced vagal 
activity (Gidron, Kupper, Kwaijtaal, Winter, & Denollet, 
2007). As resilience is the capacity to overcome adverse 
events and to be able to develop oneself successfully 
despite very adverse circumstances, the most plausible 
explanation might be that resilience reduces (i.e., has a 
“buffering” effect against) the negative effects of 
stress.
Limitations of the study
We investigated whether resilience is a protective 
psychological factor in CHD. The extent to what other 
potential protective factors (e.g., hardiness; Beasley, 
Thompson, & Davidson, 2003) have similar effects should 
be investigated in future research (Hartley, 2012). 
Participants in our study were a small sample of patients 
with ACS. Future research can also investigate whether our 
results hold in larger samples of healthy individuals and in 
patients with stable coronary heart disease. In addition, we 
used leukocytes (i.e., WBC count) and neurophils as an 
inflammatory marker. We did not investigate whether our 
results hold consistently in different subtypes of white 
blood cells (Widmaier et al., 2011; i.e. CD4 or CD8 T-cells). 
Future research should also investigate if some of these 
cell types fully mediate the relationship between resilience 
and severity in the acute setting of an ACS. Finally, we used 
a cross-sectional design in our study. Although our study can 
provide important theoretical insights, future search can 
investigate if our results hold consistently in a study using a 
longitudinal design. 
Conclusions
Our research demonstrates that resilience decreases the 
size of the myocardial infarction in patients with ACS by 
affecting the inflammatory response. Thus, inflammation is 
a plausible mechanism affecting the influence that this 
psychological factor has on the prognosis after an acute 
coronary event. We hope that our study encourages future 
research investigating whether psychological therapy at 
early stages of CVD increases resilience in patients at high 
risk. 
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